Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat in Women With Polycystic Ovary Syndrome (PCOS)
NCT07747909Recruiting
- Sponsor
- Khyber Medical University
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Orlistat + Standard Lifestyle Advice with Placebo + Standard Lifestyle Advice (2 arms). Primary endpoints: Polycystic Ovary Syndrome Features at 3 months, Luteinizing Hormone/Follicle Stimulating Hormone Ratio at 3 months and 5 more. Started Jan 2026; status: recruiting.
02
Drugs
orlistat
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07747909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07747909.